Discover
GANX
Gain Therapeutics, Inc.
1.64
2 x 1.28
2 x 2.27
bid
ask
+
0.02
1.55%
2 @ 07:57 PM
1.66 +0.02 (1.22%)
| Ytd | -49.07% | |
| 1y | -21.15% |
1.61
day range
1.66
1.59
52 week range
4.18
| Open | 1.61 | Prev Close | 1.61 | Low | 1.61 | High | 1.66 | Mkt Cap | 71.58M |
| Vol | 328.69K | Avg Vol | 493.98K | EPS | -0.51 | P/E | N/A | Forward P/E | -1.76 |
| Beta | 0.34 | Short Ratio | 1.65 | Inst. Own | 7.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.82 | 200-d Avg | 1.98 | 1yr Est | 7.33 |
| Income Statement | |||
| Operating Expenses | 4.68M | ||
| Research and Development Expense | 2.14M | ||
| Selling, General and Administrative Expense | 2.54M | ||
| Operating Income | -4.68M | ||
| Income Tax Expense | 104.07K | ||
| Net Income | -4.68M | ||
| Net Income Common Stock | -4.68M | ||
| Net Income Common Stock (USD) | -4.68M | ||
| Consolidated Income | -4.68M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -4.57M | ||
| Earning Before Interest & Taxes (USD) | -4.57M | ||
| Weighted Average Shares | 42.88M | ||
| Weighted Average Shares Diluted | 42.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.08M | ||
| Cash and Equivalents (USD) | 13.08M | ||
| Investments | 35.59K | ||
| Investments Non-Current | 35.59K | ||
| Current Assets | 14.97M | ||
| Property, Plant & Equipment Net | 313.89K | ||
| Total Assets | 15.42M | ||
| Debt Current | 233.06K | ||
| Total Debt | 609.87K | ||
| Current Liabilities | 3.43M | ||
| Debt Non-Current | 376.82K | ||
| Total Liabilities | 4.13M | ||
| Accumulated Retained Earnings (Deficit) | -111.64M | ||
| Accumulated Other Comprehensive Income | 1.00M | ||
| Shareholders Equity | 11.29M | ||
| Shareholders Equity (USD) | 11.29M | ||
| Assets Non-Current | 452.19K | ||
| Total Debt (USD) | 609.87K | ||
| Goodwill and Intangible Assets | 76.78K | ||
| Liabilities Non-Current | 696.04K | ||
| Trade and Non-Trade Payables | 1.22M | ||
| Tax Assets | 210.49K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.17K | ||
| Net Cash Flow from Financing | 1.37M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.46M | ||
| Issuance (Purchase) of Equity Shares | 1.39M | ||
| Issuance (Repayment) of Debt Securities | -25.30K | ||
| Net Cash Flow from Operations | -4.68M | ||
| Effect of Exchange Rate Changes on Cash | -141.63K | ||
| Share Based Compensation | 566.05K | ||